This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version    RSS    Subscribe    Unsubscribe    Archive    Media Kit           Jan. 22, 2014

Home     About SGO    Education    Membership    Clinical Practice    Public Policy    Blog    Partnerships    Store

 

Phase 2 trial of Bevacizumab (Avastin) in locally advanced cervical cancer found 'promising'
Science Daily
An article published in the January issue of the International Journal of Radiation Oncology, Biology and Physics reports results of the Radiation Therapy Oncology Group phase II clinical trial of Bevacizumab (Avastin) in addition to cisplatin and pelvic radiation for locally advanced cervical cancer. The group reports that the addition of Bevacizumab to the existing standard of care was safe and showed promising overall results. The two- and three- year overall survival rates were 89.8 percent and 80.2 percent, respectively.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




CERVICAL CANCER


HPV vaccine and others safe, effective when coadministered
Medscape
Adding a human papillomavirus vaccine to a child's other immunizations does not affect the safety or efficacy of any of the vaccines involved, a new study suggests. In a systematic review of 9 studies, "[n]oninferiority of immune response and an acceptable safety profile were demonstrated when HPV vaccine was coadministered with other vaccines" in all but one of the investigations, Alinea S. Noronha, M.D., from the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, and coauthors write in an article published online in Vaccine.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
PRODUCT SHOWCASE
  Work for the best

We are seeking a gyn-oncologist to join our growing health system in Springfield, Mo. Our clinic has on-site lab and radiology services, access to a da Vinci® surgical robot and a strong support staff. For more information about this opportunity at our physician owned and operated clinic, call 1-800-869-4201.
 


Testing for HPV allows for longer time between screening tests
News-Medical.net
A new study from Karolinska Institutet in Sweden finds that testing for human papillomavirus allows for longer time between screening tests when compared to cytology-based testing. The study is published in the scientific journal British Medical Journal. Until now, it has been unclear whether HPV-based screening results in overdiagnosis of lesions that would not have progressed to cancer. Also, it has not been clear whether, if implemented, the screening interval could be prolonged when using HPV-based screening.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Cervical cancer screening found to benefit older women
HealthDay News via U.S. News & World Report
Cervical cancer screening beyond age 50 saves lives and remains beneficial to women up to age 69, a new British study suggests. Both the U.S. Centers for Disease Control and Prevention and the U.S. Preventive Services Task Force recommend that cervical cancer screening end at age 65. In this new study, researchers examined data from all 1,341 women aged 65 to 83 in England and Wales who were diagnosed with cervical cancer between 2007 and 2012, and compared them to women in the same age group who did not have cervical cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
Advertisement
A Medical
‘Must Have’

Morrow’s Gynecologic Cancer Surgery, 2nd Edition is an invaluable comprehensive surgical text book resource containing step-by-step written and illustrated descriptions of all the important operations in the field of gynecologic oncology.
Advertisement
Advertise here!

To find out how to feature your company in the SGO News Brief and other advertising opportunities, Contact Tom Crist at 972-402-7724.
MORE


BREAST CANCER


More evidence lumpectomy for early breast cancer is safe
Reuters
A new review of a decade's worth of U.S. cancer statistics finds that women who got breast-conserving surgery and radiation to treat early-stage cancer were less likely to die from breast cancer during the next 10 years than those who had their breasts removed. Researchers found that 94 percent of women who had lumpectomy and radiation between 1998 and 2008 had not died of breast cancer after 10 years, compared to about 90 percent of the women who had mastectomy, with or without radiation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Challenge rises to Pakistan's breast cancer taboos
Medical Xpress
In Pakistan, a country where breast cancer kills more women than terrorist attacks, an awareness group couldn't even say the word "breast" while talking at a university about mammograms and how to check for lumps. They had to use the euphemism "cancer of women" to discuss a disease often shrouded in social stigma in this majority Muslim nation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




RIGHT TO DIE


New Mexico judge affirms right to 'aid in dying'
Los Angeles Times
In a case involving a woman diagnosed with uterine cancer, a New Mexico judge has ruled that terminally ill patients have the right to "aid in dying" under the state constitution. "Such deaths are not considered 'suicide' under New Mexico's assisted suicide statute," ruled Judge Nan G. Nash of the 2nd District Court in Albuquerque. The state's assisted suicide law classifies helping with suicide as a fourth-degree felony. Aid in dying refers to doctors prescribing a fatal dose of drugs so patients can "achieve a peaceful death and thereby avoid further suffering," Nash wrote.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



Women's Cancer News
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Caitlin McNeely, Content Editor, 469.420.2692  
Contribute news


Inclusion of advertisements does not constitute SGO endorsement of company products or services.

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the Women's Cancer News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

Jan. 15, 2014
Jan. 8, 2014
Jan. 3, 2013
Dec. 25, 2013






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063